113 related articles for article (PubMed ID: 22041986)
1. The identification of two subgroups of obese women with differing endometrial proliferation levels: potential consequences in the development of endometrial cancer.
Villavicencio A; Aguilar G; Acuña J; Gabler F; Soto E; Gaete F; Peñaloza P; Celis M; Owen GI
Int J Obes (Lond); 2012 Jul; 36(7):1012-5. PubMed ID: 22041986
[TBL] [Abstract][Full Text] [Related]
2. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
[TBL] [Abstract][Full Text] [Related]
4. Induction of post-menstrual regeneration by ovarian steroid withdrawal in the functionalis of xenografted human endometrium.
Coudyzer P; Lemoine P; Po C; Jordan BF; Van Der Smissen P; Courtoy PJ; Henriet P; Marbaix E
Hum Reprod; 2015 May; 30(5):1156-68. PubMed ID: 25750204
[TBL] [Abstract][Full Text] [Related]
5. The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria.
Villavicencio A; Aguilar G; Argüello G; Dünner C; Gabler F; Soto E; Gaete F; Peñaloza P; Celis M; Rojas C
Gynecol Oncol; 2010 Apr; 117(1):96-102. PubMed ID: 20074784
[TBL] [Abstract][Full Text] [Related]
6. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.
Pabona JMP; Burnett AF; Brown DM; Quick CM; Simmen FA; Montales MTE; Liu SJ; Rose T; Alhallak I; Siegel ER; Simmen RC
Reprod Sci; 2020 Jan; 27(1):267-277. PubMed ID: 32046384
[TBL] [Abstract][Full Text] [Related]
7. A20-mediated deubiquitination of ERα in the microenvironment of CD163
Lv Q; Xie L; Cheng Y; Shi Y; Shan W; Ning C; Xie B; Yang B; Luo X; He Q; Zhu Q; Zhang Y; Zhang Z; Wang C; Chen X; Xu C
Cancer Lett; 2019 Feb; 442():137-147. PubMed ID: 30420335
[TBL] [Abstract][Full Text] [Related]
8. SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer.
Penolazzi L; Bonaccorsi G; Gafà R; Ravaioli N; Gabriele D; Bosi C; Lanza G; Greco P; Piva R
Gene; 2019 Aug; 711():143938. PubMed ID: 31220580
[TBL] [Abstract][Full Text] [Related]
9. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
McCampbell AS; Mittelstadt ML; Dere R; Kim S; Zhou L; Djordjevic B; Soliman PT; Zhang Q; Wei C; Hursting SD; Lu KH; Broaddus RR; Walker CL
Curr Mol Med; 2016; 16(3):252-65. PubMed ID: 26917264
[TBL] [Abstract][Full Text] [Related]
10. Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer.
Uzan J; Laas E; Alsamad IA; Skalli D; Mansouri D; Haddad B; Touboul C
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28505082
[TBL] [Abstract][Full Text] [Related]
11. [Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma (author's transl)].
Pollow K; Boquoi E
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):231-42. PubMed ID: 185824
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptors (α, β), cyclooxygenase-2 and aromatase in normal endometrium and endometrioid cancer of uterus.
Knapp P; Chabowski A; Błachnio-Zabielska A; Walentowicz-Sadłecka M; Grabiec M; Knapp PA
Adv Med Sci; 2013; 58(1):96-103. PubMed ID: 23625281
[TBL] [Abstract][Full Text] [Related]
13. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
14. Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines.
Collins G; Mesiano S; DiFeo A
Reprod Sci; 2019 May; 26(5):609-618. PubMed ID: 29848180
[TBL] [Abstract][Full Text] [Related]
15. Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer.
Modesitt SC; Hsu JY; Chowbina SR; Lawrence RT; Hoehn KL
Int J Gynecol Cancer; 2012 Jun; 22(5):732-41. PubMed ID: 22635025
[TBL] [Abstract][Full Text] [Related]
16. Association of body mass index with ER, PR and 14-3-3σ expression in tumor and stroma of type I and type II endometrial carcinoma.
Peevey JF; Seagle BL; Maniar KP; Kim JJ
Oncotarget; 2017 Jun; 8(26):42548-42559. PubMed ID: 28476021
[TBL] [Abstract][Full Text] [Related]
17. MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling.
Omar IS; Abd Jamil AH; Mat Adenan NA; Chung I
PLoS One; 2022; 17(7):e0270830. PubMed ID: 35816477
[TBL] [Abstract][Full Text] [Related]
18. miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.
Bao W; Zhang Y; Li S; Fan Q; Qiu M; Wang Y; Li Y; Ji X; Yang Y; Sang Z; Xu W; Yang Y; Wu S; Zhu Y
Oncol Rep; 2019 Mar; 41(3):1575-1585. PubMed ID: 30569100
[TBL] [Abstract][Full Text] [Related]
19. A functional role of LEFTY during progesterone therapy for endometrial carcinoma.
Fei W; Kijima D; Hashimoto M; Hashimura M; Oguri Y; Kajita S; Matsumoto T; Yokoi A; Saegusa M
Cell Commun Signal; 2017 Dec; 15(1):56. PubMed ID: 29268772
[TBL] [Abstract][Full Text] [Related]
20. Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.
Lin CY; Chao A; Wang TH; Lee LY; Yang LY; Tsai CL; Wang HS; Lai CH
Oncotarget; 2016 Sep; 7(37):60038-60052. PubMed ID: 27527851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
